Quest Diagnostics (DGX) Up 13% Following Q3 Numbers, Outlook
Tweet
Share
E-mail
Quest Diagnostics (NYSEL DGX) is ripping higher today, following third-quarter financials and boosted dividend.
Earlier, Quest reported Q3 EPS of $1.18, 7 cents better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
The stock is up over 13 percent Tuesday.
Earlier, Quest reported Q3 EPS of $1.18, 7 cents better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
The stock is up over 13 percent Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MarketWise Q2 billings rise 56% year-over-year to $91M
- ISS and Glass Lewis back Aterian asset sale ahead of shareholder vote
- Phillips 66 (PSX) Declares $1.27 Quarterly Dividend; 2.7% Yield
Create E-mail Alert Related Categories
Insiders' BlogRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
